ALG-15426-39754
4 vaccinations
1 coded response
40 check-ins
1 free-text entry
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 554 / MN
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-04
Registered in v-safe
-
2021-01-04
Health check-in — day 7, dose 1Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-04
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-07
-
2021-01-13
Dose 2 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-20
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-25
-
2021-04-14
Survey response — 3 months, dose 2MedDRA: Hyperprolactinaemia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: HyperprolactinemiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-07
- 2021-07-14
-
2021-12-11
Dose 3 — Pfizer-BioNTech
-
2021-12-12
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-12-13
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-12-14
- 2021-12-15
- 2021-12-16
- 2021-12-17
- 2021-12-18
- 2021-12-26
- 2022-01-03
- 2022-01-08
- 2022-01-15
- 2022-01-22
- 2022-03-12
- 2022-06-11
-
2022-11-04
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-10
- 2022-11-11
- 2022-11-20
- 2022-11-27
- 2022-12-02
- 2022-12-09
- 2022-12-16
- 2023-02-07
- 2023-05-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-12-11 | Pfizer-BioNTech | No |
| 4 | 2022-11-04 | Pfizer-BioNTech | Flu |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 7 — 3 months, dose 2
Symptoms: Hyperprolactinemia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hyperprolactinaemia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release